| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adrenal crisis-induced cardiogenic shock (ACCS): a comprehensive review
|
Heidarpour, Maryam
|
|
|
30 |
1 |
p. 227-246
|
artikel
|
| 2 |
Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction
|
Wang, Tian-Yu
|
|
|
30 |
1 |
p. 17-38
|
artikel
|
| 3 |
BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis
|
Ammar, Lama A.
|
|
|
30 |
1 |
p. 45-54
|
artikel
|
| 4 |
Changing the paradigm in heart failure: shifting from treatment to prevention
|
Chang, Alex J.
|
|
|
30 |
1 |
p. 177-189
|
artikel
|
| 5 |
Contextualizing the results of HELIOS-B in the broader landscape of clinical trials for the treatment of transthyretin cardiac amyloidosis
|
Girard, Andrew A.
|
|
|
30 |
1 |
p. 69-73
|
artikel
|
| 6 |
Dietary sodium intake restriction in patients with heart failure: an overview of systematic reviews
|
Liu, Congying
|
|
|
30 |
1 |
p. 143-157
|
artikel
|
| 7 |
Epigenetics of cardiomyopathies: the next frontier
|
Hajdarpašić, Aida
|
|
|
30 |
1 |
p. 257-270
|
artikel
|
| 8 |
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
|
Bonfioli, Giovanni Battista
|
|
|
30 |
1 |
p. 131-136
|
artikel
|
| 9 |
Heart failure with preserved ejection fraction and atrial fibrillation: catheter ablation vs. standard medical therapy — a systematic review and meta-analysis
|
Mahalleh, Mehrdad
|
|
|
30 |
1 |
p. 1-15
|
artikel
|
| 10 |
Heart failure with reduced ejection fraction and chronic kidney disease: a focus on therapies and interventions
|
Taha, Hesham Salah Eldin
|
|
|
30 |
1 |
p. 159-175
|
artikel
|
| 11 |
In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure
|
Arshad, Muhammad Sameer
|
|
|
30 |
1 |
p. 89-101
|
artikel
|
| 12 |
Machine learning in the prevention of heart failure
|
Hamid, Arsalan
|
|
|
30 |
1 |
p. 117-129
|
artikel
|
| 13 |
Mineralocorticoid receptor antagonists and heart failure with preserved ejection fraction: current understanding and future prospects
|
Chen, Xi
|
|
|
30 |
1 |
p. 191-208
|
artikel
|
| 14 |
Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCM
|
Beghini, Alberto
|
|
|
30 |
1 |
p. 39-43
|
artikel
|
| 15 |
Pericardiotomy as a novel treatment for heart failure with preserved ejection fraction
|
Doi, Shunichi
|
|
|
30 |
1 |
p. 137-142
|
artikel
|
| 16 |
Potential of plasma biomarkers for heart failure prediction, management, and prognosis: A multiomics perspective
|
Zou, Erhou
|
|
|
30 |
1 |
p. 55-67
|
artikel
|
| 17 |
Sodium-glucose cotransporter-2 inhibitors in acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
|
Coelho Meine, Matheus
|
|
|
30 |
1 |
p. 219-226
|
artikel
|
| 18 |
The chronobiology of human heart failure: clinical implications and therapeutic opportunities
|
Gentile, Francesco
|
|
|
30 |
1 |
p. 103-116
|
artikel
|
| 19 |
The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy
|
Vouloagkas, Ioannis
|
|
|
30 |
1 |
p. 247-256
|
artikel
|
| 20 |
The role of coronary microcirculation in heart failure with preserved ejection fraction: An unceasing odyssey
|
Dimitriadis, Kyriakos
|
|
|
30 |
1 |
p. 75-88
|
artikel
|
| 21 |
The sympathetic nervous system in heart failure with preserved ejection fraction
|
Chang, Joshua W.-H.
|
|
|
30 |
1 |
p. 209-218
|
artikel
|
Tijdschrift beschrijving